|
1
|
Collavin L, Lunardi A and Del Sal G:
p53-family proteins and their regulators: hubs and spokes in tumor
suppression. Cell Death Differ. 17:901–911. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qian Y and Chen X: Tumor suppression by
p53: making cells senescent. Histol Histopathol. 25:515–526.
2010.PubMed/NCBI
|
|
3
|
Menendez D, Inga A and Resnick MA: The
expanding universe of p53 targets. Nat Rev Cancer. 9:724–737. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hermeking H: The miR-34 family in cancer
and apoptosis. Cell Death Differ. 17:193–199. 2010. View Article : Google Scholar
|
|
5
|
Hermeking H: MicroRNAs in the p53 network:
micromanagement of tumour suppression. Nat Rev Cancer. 12:613–626.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shin S, Cha HJ, Lee EM, et al: MicroRNAs
are significantly influenced by p53 and radiation in HCT116 human
colon carcinoma cells. Int J Oncol. 34:1645–1652. 2009.PubMed/NCBI
|
|
7
|
He L, He X, Lowe SW and Hannon GJ:
microRNAs join the p53 network - another piece in the
tumour-suppression puzzle. Nat Rev Cancer. 7:819–822. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Feng Z, Zhang C, Wu R and Hu W: Tumor
suppressor p53 meets microRNAs. J Mol Cell Biol. 3:44–50. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang W and Cohen SM: The Hippo pathway
acts via p53 and microRNAs to control proliferation and
proapoptotic gene expression during tissue growth. Biol Open.
2:822–828. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liao JM, Cao B, Zhou X and Lu H: New
insights into p53 functions through its target microRNAs. J Mol
Cell Biol. 6:206–213. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tarasov V, Jung P, Verdoodt B, et al:
Differential regulation of microRNAs by p53 revealed by massively
parallel sequencing: miR-34a is a p53 target that induces apoptosis
and G1-arrest. Cell Cycle. 6:1586–1593. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chang TC, Wentzel EA, Kent OA, et al:
Transactivation of miR-34a by p53 broadly influences gene
expression and promotes apoptosis. Mol Cell. 26:745–752. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Raver-Shapira N, Marciano E, Meiri E, et
al: Transcriptional activation of miR-34a contributes to
p53-mediated apoptosis. Mol Cell. 26:731–743. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bommer GT, Gerin I, Feng Y, et al:
p53-mediated activation of miRNA34 candidate tumor-suppressor
genes. Curr Biol. 17:1298–1307. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Corney DC, Flesken-Nikitin A, Godwin AK,
Wang W and Nikitin AY: MicroRNA-34b and microRNA-34c are targets of
p53 and cooperate in control of cell proliferation and
adhesion-independent growth. Cancer Res. 67:8433–8438. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
He L, He X, Lim LP, et al: A microRNA
component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liao JM, Zhou X, Zhang Y and Lu H:
miR-1246: a new link of the p53 family with cancer and Down
syndrome. Cell Cycle. 11:2624–2630. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Liao JM, Zeng SX and Lu H: p53
downregulates Down syndrome-associated DYRK1A through miR-1246.
EMBO Rep. 12:811–817. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li W, Wu YF, Xu RH, Lu H, Hu C and Qian H:
miR-1246 releases RTKN2-dependent resistance to UVB-induced
apoptosis in HaCaT cells. Mol Cell Biochem. 394:299–306. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen J, Yao D, Zhao S, et al: MiR-1246
promotes SiHa cervical cancer cell proliferation, invasion, and
migration through suppression of its target gene thrombospondin 2.
Arch Gynecol Obstet. 290:725–732. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu LJ, Jiang T, Zhao W, et al: Parallel
mRNA and microRNA profiling of HEV71-infected human neuroblastoma
cells reveal the up-regulation of miR-1246 in association with DLG3
repression. PLoS One. 9:e952722014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
23
|
Huang S and He X: The role of microRNAs in
liver cancer progression. Br J Cancer. 104:235–240. 2011.
View Article : Google Scholar :
|
|
24
|
Wu N, Liu X, Xu X, et al: MicroRNA-373, a
new regulator of protein phosphatase 6, functions as an oncogene in
hepatocellular carcinoma. FEBS J. 278:2044–2054. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou L, Yang ZX, Song WJ, et al:
MicroRNA-21 regulates the migration and invasion of a stem-like
population in hepatocellular carcinoma. Int J Oncol. 43:661–669.
2013.PubMed/NCBI
|
|
26
|
Zhou J, Lu S, Yang S, et al: MicroRNA-127
post-transcriptionally downregulates Sept7 and suppresses cell
growth in hepatocellular carcinoma cells. Cell Physiol Biochem.
33:1537–1546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen C, Ridzon DA, Broomer AJ, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma L, Young J, Prabhala H, et al: miR-9, a
MYC/MYCN-activated microRNA, regulates E-cadherin and cancer
metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
29
|
Tang H, Yao L, Tao X, et al: miR-9
functions as a tumor suppressor in ovarian serous carcinoma by
targeting TLN1. Int J Mol Med. 32:381–388. 2013.PubMed/NCBI
|
|
30
|
Dooley AL, Winslow MM, Chiang DY, et al:
Nuclear factor I/B is an oncogene in small cell lung cancer. Genes
Dev. 25:1470–1475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Moon HG, Hwang KT, Kim JA, et al: NFIB is
a potential target for estrogen receptor-negative breast cancers.
Mol Oncol. 5:538–544. 2011. View Article : Google Scholar : PubMed/NCBI
|
